MCRB
Seres Therapeutics, Inc. (MCRB)
NASDAQ · Healthcare
Seres Therapeutics, Inc. annual/quarterly revenue history and growth rate from 2015 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Seres Therapeutics, Inc. revenue for the quarter ending March 31, 2026 was 358000.
- Seres Therapeutics, Inc. revenue for the twelve months ending March 31, 2026 was 709000, a 99.44% decrease year-over-year.
- Seres Therapeutics, Inc. annual revenue for 2025 was 789000.
- Seres Therapeutics, Inc. annual revenue for 2024 was 0.
- Seres Therapeutics, Inc. annual revenue for 2023 was 0, a 100.00% decrease from 2022.
- Seres Therapeutics, Inc. annual revenue for 2022 was 7.1 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Seres Therapeutics, Inc. Earnings — FAQ
Seres Therapeutics, Inc. (MCRB) earnings over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MCRB's earnings history?
The chart and table above show Seres Therapeutics, Inc.'s earnings by year and by quarter, including the growth rate.